Hopkins GIM: What's New

Becker Team on the Road to AHA

Congratulations to Dr. Diane Becker and her team, who are in Chicago, Illinois (November 12-15, 2006) to present 10 abstracts at the American Heart Association's annual "Scientific Sessions." The annual meeting encompasses four days of invited lectures and investigative reports. Simultaneous presentations represent all fields of cardiovascular, cerebrovascular, and related disciplines. Dr. Becker and her GIM colleagues, Dr. Dhananjay Vaidya, Enrique Herrera-Galeano, Lisa Yanek, and Taryn Moy, as well as Drs. Nauder Faraday and Lewis Becker, are presenting the following abstracts currently in press:

A genome wide scan supports linkage of collagen-induced platelet aggregation following aspirin therapy to the D15S1005 locus. Circulation 2006, in press. (Herrera-Galeano JE, Vaidya D, Faraday N, Yanek LR, Moy TF, Becker DM, Becker LC)

A novel variant in the platelet endothelial aggregation receptor-1 gene is associated with decreased response to aspirin. Circulation 2006, in press. (Herrera-Galeano JE, Becker DM, Yanek LR, Moy TF, Faraday N, Becker LC) 

 Gene variants in collagen signaling alter platelet function and response to aspirin. Circulation 2006, in press. (Faraday N, Herrera-Galeano JE, Yanek LR, Moy TF, Bray PF, Becker DM, Becker LC)

Genetic variation in cyclooxygenase-dependent platelet activation is an uncommon cause of diminished aspirin responsiveness. Circulation 2006, in press. (Faraday N, Herrera-Galeano JE, Yanek LR, Moy TF, Bray PF, Becker DM, Becker LC)

Heritability of platelet aspirin responsiveness. Circulation 2006, in press. (Faraday N, Yanek LR, Mathias R, Herrera-Galeano JE, Moy TF, Bray PF, Becker LC, Becker DM)

The metabolic syndrome is associated with hyperaggregable platelets. Circulation 2006, in press. (Vaidya DF, Yanek LR, Faraday N, Moy TF, Becker LC, Becker DM)

Casual chocolate consumption and platelet function. Circulation 2006, in press. (Becker DM, Yanek LR, Moy TF, Becker LC, Faraday N)

The sustained impact of a community-based risk factor reduction program on ldl cholesterol goals in a high risk african american population. Circulation 2006, in press. (Wiley C, Yanek LR, Bordeaux B, Moy TF, Levine DM, Becker DM)

A VAMP8 gene variant is associated with coronary heart disease in The Johns Hopkins Sibling Study. Circulation 2006, in press. (Shiffman D, Rowland CM, Louie JZ, Catanese JJ, Yanek LR, Herrera JE, Becker LC, Devlin JJ, Becker DM)

A High Level of High Density Lipoprotein Cholesterol Does Not Protect Against Incident Coronary Artery Disease in Families with Premature Coronary Disease. Circulation 2006, in press. (Kral BG, Becker LC, Yanek LR, Moy TF, Becker DM)